SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Ex vivo host transcriptomics during Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans infection of PBMCs from South African volunteers

Doyle, RM; Kannambath, S; Pittman, A; Goliath, R; Kumar, V; Meintjes, G; Milburn, J; Netea, MG; Harrison, TS; Jarvis, JN; et al. Doyle, RM; Kannambath, S; Pittman, A; Goliath, R; Kumar, V; Meintjes, G; Milburn, J; Netea, MG; Harrison, TS; Jarvis, JN; Bicanic, T (2024) Ex vivo host transcriptomics during Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans infection of PBMCs from South African volunteers. The Journal of Infectious Diseases. ISSN 0022-1899 https://doi.org/10.1093/infdis/jiae410
SGUL Authors: Pittman, Alan Michael Bicanic, Tihana

[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Archive (ZIP) (Supplementary data) Supplemental Material
Download (1MB)

Abstract

Cryptococcus neoformans, Cryptococcus gattii and Candida albicans are opportunistic fungal pathogens associated with infections in immunocompromised hosts. Cryptococcal meningitis (CM) is the leading fungal cause of HIV-related deaths globally, with the majority occurring in Africa. The human immune response to C. albicans infection has been studied extensively in large genomics studies whereas cryptococcal infections, despite their severity, are comparatively understudied. Here we investigated the transcriptional response of immune cells after in vitro stimulation with in vitro C. neoformans, C. gattii and C. albicans infection of peripheral blood mononuclear cells (PBMCs) collected from healthy South African volunteers. We found a lower transcriptional response to cryptococcal stimuli compared to C. albicans and unique expression signatures from all three fungal stimuli. This work provides a starting point for further studies comparing the transcriptional signature of CM in immunocompromised patients, with the goal of identifying biomarkers of disease severity and possible novel treatment targets.

Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: 06 Biological Sciences, 11 Medical and Health Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Academic Structure > REF 2021 user group
Journal or Publication Title: The Journal of Infectious Diseases
ISSN: 0022-1899
Language: en
Dates:
DateEvent
19 August 2024Published Online
15 August 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
RP-2017–08-ST2-012National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
097377/Z/11/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
URI: https://openaccess.sgul.ac.uk/id/eprint/116767
Publisher's version: https://doi.org/10.1093/infdis/jiae410

Actions (login required)

Edit Item Edit Item